Page last updated: 2024-09-04

thiazolo(3,2-a)perimidine and Colorectal Neoplasms

thiazolo(3,2-a)perimidine has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, M; Li, R; Wang, H; Wang, J	1

Other Studies

1 other study(ies) available for thiazolo(3,2-a)perimidine and Colorectal Neoplasms

Article	Year
PB-10, a thiazolo[4,5-d] pyrimidine derivative, targets p21-activated kinase 4 in human colorectal cancer cells. Bioorganic & medicinal chemistry letters, 2020, 01-15, Volume: 30, Issue:2 Topics: Binding Sites; Cell Adhesion; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Design; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Molecular Docking Simulation; p21-Activated Kinases; Protein Kinase Inhibitors; Pyrimidines; RNA Interference; RNA, Small Interfering; Thiazoles	2020

Article

Year

PB-10, a thiazolo[4,5-d] pyrimidine derivative, targets p21-activated kinase 4 in human colorectal cancer cells.

Bioorganic & medicinal chemistry letters, 2020, 01-15, Volume: 30, Issue:2

Topics: Binding Sites; Cell Adhesion; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Design; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Molecular Docking Simulation; p21-Activated Kinases; Protein Kinase Inhibitors; Pyrimidines; RNA Interference; RNA, Small Interfering; Thiazoles

2020